Vaccine Integrity Project Urges Continuing HBV Vaccinations for Newborns

December 4, 2025

On December 2, the Vaccine Integrity Project (VIP) released a study on the safety, effectiveness, and public health impact of hepatitis B virus (HBV) vaccinations at birth.  

VIP, a project by the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, released the report two days before the Advisory Committee on Immunization Practice (ACIP) was scheduled to meet to discuss whether to end the practice of vaccinating all newborns for HBV. The practice has been in place since 1991. 

VIP found the following in its review of data: 

  • Given the long-term protection provided by the hepatitis B vaccine, the birth dose was also key in reducing HBV transmission, disease, and death in the U.S. overall.  

  • No safety benefits were identified for a delayed first dose versus vaccination at birth.   

  • Delaying the first dose leaves infants vulnerable to both undiagnosed maternal infection and HBV exposure after birth.   

The data review found no benefit of delaying vaccinations.  

See the full report here.  

Latest News

$84 Million Malpractice Verdict Awarded

October 8, 2026

On September 29, a Hennepin County jury issued an $84 million malpractice verdict against Fairview Health Services, in a case involving a patient who died of complications following an exercise-induced heart attack.  

St. Cloud Fifth Graders Experience Mini Medical School

October 8, 2026

A group of fifth-grade students from Lincoln Elementary School in St. Cloud got a firsthand look at the world of medicine on October 5, during a special Mini Medical School Day hosted by the University of Minnesota Medical School CentraCare Regional Campus St. Cloud.

MMA Updates its “One Big Beautiful Bill Act” Guide

October 8, 2026

On October 7, the MMA released an updated version of its “The One Big Beautiful Bill Act (OBBBA) Resource Guide for Physicians.”